Counterbalancing the effects of oxidative stress by up-regulation of Nrf2 signaling has been shown to be effective in various disease models where oxidative stress is implicated, including Alzheimer’s disease. The gene discussed is NFE2L2; the disease is early-onset autosomal dominant Alzheimer disease.